Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Bin Shi, James Hardwick, Brett Connolly, Xianzhi Mao, Rosemary McFall, Susan Hill, Kenneth A. Thomas, Nancy E. Kohl & Laura Sepp-Lorenzino. (2010) Immunohistochemical Detection of Antitumor, Antimetastasis, and Antiangiogenesis Effects of a Vascular Endothelial Growth Factor Receptor 2 Kinase Inhibitor in an Orthotopic Breast Cancer Metastasis Model. Journal of Histotechnology 33:1, pages 15-24.
Read now
Read now
Rowena S Lewis & Alister C Ward. (2008) Stat5 as a diagnostic marker for leukemia. Expert Review of Molecular Diagnostics 8:1, pages 73-82.
Read now
Read now
Articles from other publishers (21)
Kewei Yu, Juan Wang, Junhui Hou, Lei Zhang & Hui Liang. (2022) miR-338-3p Plays a Significant Role in Casticin-Induced Suppression of Acute Myeloid Leukemia via Targeting PI3K/Akt Pathway. BioMed Research International 2022, pages 1-11.
Crossref
Crossref
Mohsen Rashid, Leila Rostami Zadeh, Behzad Baradaran, Ommoleila Molavi, Zeinab Ghesmati, Mehdi Sabzichi & Fatemeh Ramezani. (2021) Up-down regulation of HIF-1α in cancer progression. Gene 798, pages 145796.
Crossref
Crossref
Guang Yang, Rachel Shi & Qing Zhang. (2020) Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression. International Journal of Molecular Sciences 21:21, pages 8162.
Crossref
Crossref
Guoliang Chen, Zimu Jia, Linping Wang & Tingzhang Hu. (2020) Effect of acute exposure of saxitoxin on development of zebrafish embryos (Danio rerio). Environmental Research 185, pages 109432.
Crossref
Crossref
Guoliang Chen, Linping Wang, Wenping Li, Qian Zhang & Tingzhang Hu. (2020) Nodularin induced oxidative stress contributes to developmental toxicity in zebrafish embryos. Ecotoxicology and Environmental Safety 194, pages 110444.
Crossref
Crossref
Wendi Tang & Guisen Zhao. (2020) Small molecules targeting HIF-1α pathway for cancer therapy in recent years. Bioorganic & Medicinal Chemistry 28:2, pages 115235.
Crossref
Crossref
Michelle L. Halls, Ross A. D. Bathgate, Steve W. Sutton, Thomas B. Dschietzig & Roger J. Summers. (2015) International Union of Basic and Clinical Pharmacology. XCV. Recent Advances in the Understanding of the Pharmacology and Biological Roles of Relaxin Family Peptide Receptors 1–4, the Receptors for Relaxin Family Peptides. Pharmacological Reviews 67:2, pages 389-440.
Crossref
Crossref
Azhar Rasul, Bin-Ji Zhao, Jun Liu, Bao Liu, Jia-Xin Sun, Jiang Li & Xiao-Meng Li. (2014) Molecular Mechanisms of Casticin Action: an Update on its Antitumor Functions. Asian Pacific Journal of Cancer Prevention 15:21, pages 9049-9058.
Crossref
Crossref
Heng-Xiu Yan, Wei-Wei Li, Yan Zhang, Xia-Wei Wei, Li-Xin Fu, Guo-Bo Shen, Tao Yin, Xiu-Ying Li, Hua-Shan Shi, Yang Wan, Qing-Yin Zhang, Jiong Li, Sheng-Yong Yang & Yu-Quan Wei. (2014) Accumulation of FLT3+ CD11c+ dendritic cells in psoriatic lesions and the anti-psoriatic effect of a selective FLT3 inhibitor. Immunologic Research 60:1, pages 112-126.
Crossref
Crossref
BING ZHAO & XIAOMENG LI. (2014) Altholactone induces reactive oxygen species-mediated apoptosis in bladder cancer T24 cells through mitochondrial dysfunction, MAPK-p38 activation and Akt suppression. Oncology Reports 31:6, pages 2769-2775.
Crossref
Crossref
Yang-Ming Yang, Huijuan Yuan, John G. Edwards, Yester Skayian, Kanta Ochani, Edmund J. Miller & Pravin B. Sehgal. (2014) Deletion of STAT5a/b in Vascular Smooth Muscle Abrogates the Male Bias in Hypoxic Pulmonary Hypertension in Mice: Implications in the Human Disease. Molecular Medicine 20:1, pages 625-638.
Crossref
Crossref
Domenico Ribatti. (2013) Angiogenesis as a treatment target in leukemia. International Journal of Hematologic Oncology 2:3, pages 229-242.
Crossref
Crossref
R. A. D. Bathgate, M. L. Halls, E. T. van der Westhuizen, G. E. Callander, M. Kocan & R. J. Summers. (2013) Relaxin Family Peptides and Their Receptors. Physiological Reviews 93:1, pages 405-480.
Crossref
Crossref
Antonio Rodriguez-Ariza, Chary Lopez-Pedrera, Enrique Aranda & Nuria Barbarroja. (2011) VEGF targeted therapy in acute myeloid leukemia. Critical Reviews in Oncology/Hematology 80:2, pages 241-256.
Crossref
Crossref
Amir Fathi & Mark Levis. (2011) FLT3 inhibitors: a story of the old and the new. Current Opinion in Hematology 18:2, pages 71-76.
Crossref
Crossref
Walter Fiedler, Rolf Mesters, Michael Heuser, Gerhard Ehninger, Wolfgang E. Berdel, Ute Zirrgiebel, Jane D. Robertson, Tom A. Puchalski, Barbara Collins, Juliane M. Jürgensmeier & Hubert Serve. (2010) An open-label, Phase I study of cediranib (RECENTIN™) in patients with acute myeloid leukemia. Leukemia Research 34:2, pages 196-202.
Crossref
Crossref
Jia-Kun Shen, Hua-ping Du, Min Yang, Yun-Gui Wang & Jie Jin. (2009) Casticin induces leukemic cell death through apoptosis and mitotic catastrophe. Annals of Hematology 88:8, pages 743-752.
Crossref
Crossref
Mark W. Kieran, Jeffrey G. Supko, Dana Wallace, Robert Fruscio, Tina Young Poussaint, Peter Phillips, Ian Pollack, Roger Packer, James M. Boyett, Susan Blaney, Anu Banerjee, Russ Geyer, Henry Friedman, Stewart Goldman, Larry E. Kun & Tobey MacDonald. (2008) Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors. Pediatric Blood & Cancer 52:2, pages 169-176.
Crossref
Crossref
Xue-Mei Ou, Wan-Cheng Li, Dai-Shun Liu, Yan-Ping Li, Fu-Qiang Wen, Yu-Lin Feng, Shang-Fu Zhang, Xiang-Yang Huang, Tao Wang, Ke Wang, Xun Wang & Lei Chen. (2009) VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice. International Immunopharmacology 9:1, pages 70-79.
Crossref
Crossref
C Schaefer, M Krause, I Fuhrhop, M Schroeder, P Algenstaedt, W Fiedler, W Rüther & N Hansen-Algenstaedt. (2007) Time-course-dependent microvascular alterations in a model of myeloid leukemia in vivo. Leukemia 22:1, pages 59-65.
Crossref
Crossref
Walter Stummer. (2007) Mechanisms of tumor-related brain edema. Neurosurgical Focus 22:5, pages 1-7.
Crossref
Crossref